Skip to main content
. 2021 Mar 4;13(3):e13698. doi: 10.7759/cureus.13698

Table 4. Milfetosine use in primary amoebic meningoencephalitis.

AmB: amphotericin B, Rif: rifampin, Flu: fluconazole, AZM: azithromycin, Dex: dexamethasone, Acy: acyclovir, Van: vancomycin, CFX: ceftriaxone, Deoxy AmB IV: deoxycholate amphotericin B intravenously, ICU: intensive care unit

Reference Case (age, sex) Diagnosis from symptoms onset Initial treatment¹ Miltefosine initiation from diagnosis Total days of treatment Outcome Follow up
[18] 12-year-old, female two days AmB, Rif, Flu, AZM, Dex 36 hours 55 days Survive Full recovery after three months, with speech and physical therapy
[20] 12-year-old, male one day Acy, liposomal AmB, Rif, Flu, Van, CFX , IV Deoxy AmB, Flu, AZM, Rif 31 hours 16 days Dead Braindead on hospital day 16
[20] Eight-year-old, male five days AmB, Rif, Flu, AZM, Dex 14 hours from ICU admission 39 days Survive Significant neurological deficits
[21] 44-year-old male four days IV/IT AmB, Flu, Rif, Dex Within 24 hours four days Dead Diabetes Insipidus on day three, Cardiac arrest on day four
[22] 4-year-old male for – five days LOR, Phos AZM, AmB, Rif, Flu, Dex 24 - 48 hours two days Dead Braindead on hospital day two
[22] 14-year-old male three – five days Van, CFX, Flu, AZM, Rif, IV/IT AmB 24 - 92 hours four days Dead Brain herniation, later braindead on hospital day four